BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 25987308)

  • 1. Investigation of salivary free amino acid profile for early diagnosis of breast cancer with ultra performance liquid chromatography-mass spectrometry.
    Cheng F; Wang Z; Huang Y; Duan Y; Wang X
    Clin Chim Acta; 2015 Jul; 447():23-31. PubMed ID: 25987308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigation and identification of potential biomarkers in human saliva for the early diagnosis of oral squamous cell carcinoma.
    Wang Q; Gao P; Wang X; Duan Y
    Clin Chim Acta; 2014 Jan; 427():79-85. PubMed ID: 24144867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Untargeted saliva metabonomics study of breast cancer based on ultra performance liquid chromatography coupled to mass spectrometry with HILIC and RPLC separations.
    Zhong L; Cheng F; Lu X; Duan Y; Wang X
    Talanta; 2016 Sep; 158():351-360. PubMed ID: 27343615
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigation of potential breath biomarkers for the early diagnosis of breast cancer using gas chromatography-mass spectrometry.
    Li J; Peng Y; Liu Y; Li W; Jin Y; Tang Z; Duan Y
    Clin Chim Acta; 2014 Sep; 436():59-67. PubMed ID: 24815034
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measurement of salivary metabolite biomarkers for early monitoring of oral cancer with ultra performance liquid chromatography-mass spectrometry.
    Wang Q; Gao P; Cheng F; Wang X; Duan Y
    Talanta; 2014 Feb; 119():299-305. PubMed ID: 24401418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic approach to thyroid cancer based on amino acid metabolomics in saliva by ultra-performance liquid chromatography with high resolution mass spectrometry.
    Zhang J; Wen X; Li Y; Zhang J; Li X; Qian C; Tian Y; Ling R; Duan Y
    Talanta; 2021 Dec; 235():122729. PubMed ID: 34517597
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigation of amino acid profile alterations in maternal serum for early diagnosis of anembryonic pregnancy with high performance liquid chromatography-mass spectrometry.
    Zhang M; Lu X; Mi L; Song M; Wang L; Wang X
    Eur J Obstet Gynecol Reprod Biol; 2024 Mar; 294():49-54. PubMed ID: 38215601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of Novel Diagnostic Biomarkers in Breast Cancer Using Targeted Metabolomic Profiling.
    Kozar N; Kruusmaa K; Bitenc M; Argamasilla R; Adsuar A; Takač I; Arko D
    Clin Breast Cancer; 2021 Jun; 21(3):e204-e211. PubMed ID: 33281038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Novel Multivariate Index for Pancreatic Cancer Detection Based On the Plasma Free Amino Acid Profile.
    Fukutake N; Ueno M; Hiraoka N; Shimada K; Shiraishi K; Saruki N; Ito T; Yamakado M; Ono N; Imaizumi A; Kikuchi S; Yamamoto H; Katayama K
    PLoS One; 2015; 10(7):e0132223. PubMed ID: 26133769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic approach to breast cancer patients based on target metabolomics in saliva by liquid chromatography with tandem mass spectrometry.
    Takayama T; Tsutsui H; Shimizu I; Toyama T; Yoshimoto N; Endo Y; Inoue K; Todoroki K; Min JZ; Mizuno H; Toyo'oka T
    Clin Chim Acta; 2016 Jan; 452():18-26. PubMed ID: 26523874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determination of Salivary Sialic Acid Through Nanotechnology: A Useful Biomarker for the Screening of Breast Cancer.
    Hernández-Arteaga AC; de Jesús Zermeño-Nava J; Martínez-Martínez MU; Hernández-Cedillo A; Ojeda-Galván HJ; José-Yacamán M; Navarro-Contreras HR
    Arch Med Res; 2019 Apr; 50(3):105-110. PubMed ID: 31495386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A serum microRNA classifier for early detection of hepatocellular carcinoma: a multicentre, retrospective, longitudinal biomarker identification study with a nested case-control study.
    Lin XJ; Chong Y; Guo ZW; Xie C; Yang XJ; Zhang Q; Li SP; Xiong Y; Yuan Y; Min J; Jia WH; Jie Y; Chen MS; Chen MX; Fang JH; Zeng C; Zhang Y; Guo RP; Wu Y; Lin G; Zheng L; Zhuang SM
    Lancet Oncol; 2015 Jul; 16(7):804-15. PubMed ID: 26088272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Breast cancer detection using targeted plasma metabolomics.
    Jasbi P; Wang D; Cheng SL; Fei Q; Cui JY; Liu L; Wei Y; Raftery D; Gu H
    J Chromatogr B Analyt Technol Biomed Life Sci; 2019 Jan; 1105():26-37. PubMed ID: 30562627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Taurine, glutamic acid and ethylmalonic acid as important metabolites for detecting human breast cancer based on the targeted metabolomics.
    Wang X; Zhao X; Chou J; Yu J; Yang T; Liu L; Zhang F
    Cancer Biomark; 2018; 23(2):255-268. PubMed ID: 30103303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Towards the chiral metabolomics: Liquid chromatography-mass spectrometry based DL-amino acid analysis after labeling with a new chiral reagent, (S)-2,5-dioxopyrrolidin-1-yl-1-(4,6-dimethoxy-1,3,5-triazin-2-yl)pyrrolidine-2-carboxylate, and the application to saliva of healthy volunteers.
    Mochizuki T; Takayama T; Todoroki K; Inoue K; Min JZ; Toyo'oka T
    Anal Chim Acta; 2015 May; 875():73-82. PubMed ID: 25937108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA methylation array analyses identified breast cancer-associated HYAL2 methylation in peripheral blood.
    Yang R; Pfütze K; Zucknick M; Sutter C; Wappenschmidt B; Marme F; Qu B; Cuk K; Engel C; Schott S; Schneeweiss A; Brenner H; Claus R; Plass C; Bugert P; Hoth M; Sohn C; Schmutzler R; Bartram CR; Burwinkel B
    Int J Cancer; 2015 Apr; 136(8):1845-55. PubMed ID: 25213452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The performance of a novel amino acid multivariate index for detecting lung cancer: A case control study in Korea.
    Kim HJ; Jang SH; Ryu JS; Lee JE; Kim YC; Lee MK; Jang TW; Lee SY; Nakamura H; Nishikata N; Mori M; Noguchi Y; Miyano H; Lee KY
    Lung Cancer; 2015 Dec; 90(3):522-7. PubMed ID: 26476713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Salivary metabolite signatures of oral cancer and leukoplakia.
    Wei J; Xie G; Zhou Z; Shi P; Qiu Y; Zheng X; Chen T; Su M; Zhao A; Jia W
    Int J Cancer; 2011 Nov; 129(9):2207-17. PubMed ID: 21190195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LC-MS/MS platform-based serum untargeted screening reveals the diagnostic biomarker panel and molecular mechanism of breast cancer.
    Gong S; Wang Q; Huang J; Huang R; Chen S; Cheng X; Liu L; Dai X; Zhong Y; Fan C; Liao Z
    Methods; 2024 Feb; 222():100-111. PubMed ID: 38228196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Salivary metabolomic biomarkers for non-invasive lung cancer detection.
    Kajiwara N; Kakihana M; Maeda J; Kaneko M; Ota S; Enomoto A; Ikeda N; Sugimoto M
    Cancer Sci; 2024 May; 115(5):1695-1705. PubMed ID: 38417449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.